Abstract
Despite aggressive antiplatelet therapy in the setting of PCI, the incidence of acute stent thrombosis remains approximately 0.5–2%. We report a patient with simultaneous thrombosis of two drug‐eluting coronary artery stents, suggesting a systemic thrombotic state. Evaluation by optical platelet aggregometry revealed clopidogrel resistance, which was overcome at a higher drug dose. We aim to highlight the potential utility of platelet function analysis to guide therapy for patients in whom inadequate antiplatelet therapy may have catastrophic clinical outcomes. Copyright © 2007 Wiley Periodicals, Inc.
Keywords: platelet, thrombosis, angiography, stent
Full Text
The Full Text of this article is available as a PDF (659.1 KB).
REFERENCES
- 1. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, et al.: Incidence, predictors, and outcome of thrombosis after successful implantation of drug‐eluting stents. JAMA 2005; 293: 2126. [DOI] [PubMed] [Google Scholar]
- 2. Steinhubl SR, Berger PB, Mann JT III, Fry ET, DeLago A, et al.: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002; 288: 2411. [DOI] [PubMed] [Google Scholar]
- 3.ISIS‐2 (Second International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS‐2. Lancet 1988; 2: 349. [PubMed] [Google Scholar]
- 4. Keeley EC, Grines CL: Primary percutaneous coronary intervention for every patient with ST‐segment elevation myocardial infarction: What stands in the way? Ann Intern Med 2004; 141: 298. [DOI] [PubMed] [Google Scholar]
- 5. Nguyen TA, Diodati JG, Pharand C: Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol 2005; 45: 1157. [DOI] [PubMed] [Google Scholar]
- 6. Gurbel PA, Bliden KP, Hayes KM, Yoho JA, Herzog WR, et al.: The relation of dosing to clopidogrel responsiveness and the incidence of high post‐treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 2005; 45: 1392. [DOI] [PubMed] [Google Scholar]
- 7. Samara WM, Bliden KP, Tantry US, Gurbel PA: The difference between clopidogrel responsiveness and posttreatment platelet reactivity. Thromb Res 2005; 115: 89. [DOI] [PubMed] [Google Scholar]
- 8. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, et al.: Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004; 109: 3171. [DOI] [PubMed] [Google Scholar]
- 9. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, et al.: ACC/AHA/SCAI 2005 Guideline Update for percutaneous coronary intervention‐summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47: 216. [DOI] [PubMed] [Google Scholar]
- 10. Ajzenberg N, Aubry P, Huisse MG, Cachier A, El Amara W, et al.: Enhanced shear‐induced platelet aggregation in patients who experience subacute stent thrombosis: a case‐control study. J Am Coll Cardiol 2005; 45: 1753. [DOI] [PubMed] [Google Scholar]
- 11. Wenaweser P, Dorffler‐Melly J, Imboden K, Windecker S, Togni M, et al.: Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005; 45: 1748. [DOI] [PubMed] [Google Scholar]
- 12. Gurbel PA, Bliden KP, Samara W, Yoho JA, Hayes K, et al.: Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study. J Am Coll Cardiol 2005; 46: 1827. [DOI] [PubMed] [Google Scholar]
- 13. Lee SW, Park SW, Hong MK, Kim YH, Lee BK, et al.: Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 2005; 46: 1833. [DOI] [PubMed] [Google Scholar]
- 14. Lau WC, Waskell LA, Watkins PB, Neer CJ, Horowitz K, et al.: Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug‐drug interaction. Circulation 2003; 107: 32. [DOI] [PubMed] [Google Scholar]